Literature DB >> 2540751

Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor.

K S Kovacina1, G Steele-Perkins, A F Purchio, M Lioubin, K Miyazono, C H Heldin, R A Roth.   

Abstract

Recombinant transforming growth factor (TGF)-beta 1 precursor was recently found to contain mannose 6-phosphate (Purchio et al., 1988, J. Biol. Chem. 263, 14211-14215). In the present study, recombinant TGF-beta 1 precursor was shown to bind to the insulin-like growth factor (IGF)-II/mannose 6-phosphate (man6P) receptor on the plasma membrane of cells since: 1) Insulin, which induces an increase in cell surface IGF-II/man6P receptors on adipocytes, caused a 2.7-fold increase in TGF-beta 1 precursor binding to adipocytes; 2) Chinese hamster ovary cells selected for overexpression of the IGF-II/man6P receptor exhibited an increased binding of TGF-beta 1 precursor in comparison to the parental cells; and 3) the binding of 125I-TGF-beta 1 precursor to these transfected cells and adipocytes was largely inhibited by man6P. After 15 minutes at 37 degrees C, 75% of the recombinant TGF-beta 1 precursor was found to be internalized in the transfected cells. Additional studies with latent TGF-beta 1 isolated from platelets indicated that this material could also bind to the isolated IGF-II/man6P receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540751     DOI: 10.1016/0006-291x(89)91669-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß.

Authors:  Takatoku Oida; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

Authors:  E P Böttinger; V M Factor; M L Tsang; J A Weatherbee; J B Kopp; S W Qian; L M Wakefield; A B Roberts; S S Thorgeirsson; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.

Authors:  P A Dennis; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 5.  [Mannose-6-phosphate receptors: their role in the transport of lysosomal proteins].

Authors:  K von Figura
Journal:  Naturwissenschaften       Date:  1990-03

6.  Latency-associated peptide of transforming growth factor-β1 is not subject to physiological mannose phosphorylation.

Authors:  Jarrod Barnes; Debra Warejcka; Jennifer Simpliciano; Sally Twining; Richard Steet
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 7.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

8.  A mannose-binding glycoprotein found in the 4 day post coital rat uterus is involved in pregnancy.

Authors:  M Mehta; M Chowdhury
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

9.  Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1.

Authors:  Yaoting Gui; Liam J Murphy
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

10.  Differential expression of insulin-like growth factors I and II (IGF I and II), mRNA, peptide and binding protein 1 during mouse palate development: comparison with TGF beta peptide distribution.

Authors:  M W Ferguson; P M Sharpe; B L Thomas; F Beck
Journal:  J Anat       Date:  1992-10       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.